SE392899B - Forfarande for framstellning av pyridazinderivat med psykotrop, serskilt antidepressiv verkan - Google Patents
Forfarande for framstellning av pyridazinderivat med psykotrop, serskilt antidepressiv verkanInfo
- Publication number
- SE392899B SE392899B SE7207999A SE799972A SE392899B SE 392899 B SE392899 B SE 392899B SE 7207999 A SE7207999 A SE 7207999A SE 799972 A SE799972 A SE 799972A SE 392899 B SE392899 B SE 392899B
- Authority
- SE
- Sweden
- Prior art keywords
- psychotrop
- procedure
- special
- preparation
- pyridazine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2873771 | 1971-06-18 | ||
FR7219096A FR2141697B1 (xx) | 1971-06-18 | 1972-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE392899B true SE392899B (sv) | 1977-04-25 |
Family
ID=26217112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7207999A SE392899B (sv) | 1971-06-18 | 1972-06-16 | Forfarande for framstellning av pyridazinderivat med psykotrop, serskilt antidepressiv verkan |
Country Status (13)
Country | Link |
---|---|
US (1) | US4169158A (xx) |
JP (1) | JPS5550943B1 (xx) |
AR (1) | AR192370A1 (xx) |
AU (1) | AU472247B2 (xx) |
BE (1) | BE784727A (xx) |
CA (1) | CA1003833A (xx) |
CH (1) | CH546769A (xx) |
DE (1) | DE2229215C2 (xx) |
ES (1) | ES403998A1 (xx) |
FR (1) | FR2141697B1 (xx) |
GB (1) | GB1345880A (xx) |
NL (1) | NL177893C (xx) |
SE (1) | SE392899B (xx) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2510998B1 (fr) * | 1981-08-07 | 1986-01-10 | Sanofi Sa | Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent |
FR2510997A1 (fr) * | 1981-08-10 | 1983-02-11 | Sanofi Sa | Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant |
FR2511366A1 (fr) * | 1981-08-11 | 1983-02-18 | Sanofi Sa | Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent |
FR2539741A1 (fr) * | 1983-01-21 | 1984-07-27 | Sanofi Sa | Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent |
FR2539742B1 (fr) * | 1983-01-24 | 1986-09-05 | Sanofi Sa | Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central |
FR2539739B1 (fr) * | 1983-01-24 | 1985-11-22 | Sanofi Sa | Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant |
CA1218655A (en) * | 1983-01-28 | 1987-03-03 | Kathleen Biziere | Process for the preparation of pyridazine derivatives having a psychotropic action |
FR2555178B1 (fr) * | 1983-11-18 | 1986-04-18 | Sanofi Sa | Derives cyanes de la pyridazine ayant une action psychotrope, leur mode de preparation et les medicaments en contenant |
FR2540115B1 (fr) * | 1983-01-28 | 1985-06-07 | Sanofi Sa | Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant |
FR2625201B1 (fr) * | 1987-12-24 | 1990-06-15 | Sanofi Sa | Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant |
FR2642757B1 (fr) * | 1989-02-07 | 1991-05-24 | Sanofi Sa | Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant |
PT93060B (pt) | 1989-02-07 | 1995-12-29 | Sanofi Sa | Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem |
FR2642754B1 (fr) * | 1989-02-07 | 1991-05-24 | Sanofi Sa | Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant |
US5461053A (en) * | 1989-02-07 | 1995-10-24 | Sanofi | Pyridazine derivatives |
FR2642648B1 (fr) * | 1989-02-07 | 1991-06-21 | Sanofi Sa | Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique |
US20100210590A1 (en) * | 1995-09-27 | 2010-08-19 | Northwestern University | Compositions and treatments for seizure-related disorders |
US20030176437A1 (en) | 2001-08-31 | 2003-09-18 | D.M. Watterson | Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
ES2441718T3 (es) | 2004-11-02 | 2014-02-06 | Northwestern University | Compuestos de piridazina, composiciones y métodos |
WO2006050359A2 (en) | 2004-11-02 | 2006-05-11 | Northwestern University | Pyridazine compounds and methods |
JP5121707B2 (ja) * | 2005-07-04 | 2013-01-16 | ハイ ポイント ファーマシューティカルズ,エルエルシー | 新規医薬 |
RU2442775C2 (ru) * | 2005-07-04 | 2012-02-20 | Хай Пойнт Фармасьютикалс, ЛЛС | Антагонисты гистаминовых н3-рецепторов |
EP2015750A2 (en) | 2006-04-28 | 2009-01-21 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
US20100168120A1 (en) * | 2006-04-28 | 2010-07-01 | Neuromedix Inc. | Salts of pyridazine compounds |
CN101754762A (zh) | 2006-04-28 | 2010-06-23 | 西北大学 | 用于治疗神经炎症性疾病的包含哒嗪化合物的制剂 |
JP2009537596A (ja) | 2006-05-23 | 2009-10-29 | ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー | 6−(4−シクロプロピルピペリジン−1−イル)−2’−メチル−[3,4’]−ビピリジン及びその医薬としての使用 |
SG163547A1 (en) | 2006-05-29 | 2010-08-30 | High Point Pharmaceuticals Llc | 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
EP2014656A3 (en) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
US8461389B2 (en) | 2008-04-18 | 2013-06-11 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
AR081626A1 (es) * | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
EP2560488B1 (en) | 2010-04-23 | 2015-10-28 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
WO2019145363A1 (en) | 2018-01-23 | 2019-08-01 | Institut Gustave-Roussy | Use of minaprine to reduce tumor growth |
-
1971
- 1971-06-18 GB GB2873771A patent/GB1345880A/en not_active Expired
-
1972
- 1972-05-29 FR FR7219096A patent/FR2141697B1/fr not_active Expired
- 1972-06-12 CA CA144,468A patent/CA1003833A/en not_active Expired
- 1972-06-12 BE BE784727A patent/BE784727A/xx not_active IP Right Cessation
- 1972-06-15 DE DE2229215A patent/DE2229215C2/de not_active Expired
- 1972-06-16 CH CH903672A patent/CH546769A/fr not_active IP Right Cessation
- 1972-06-16 AU AU43500/72A patent/AU472247B2/en not_active Expired
- 1972-06-16 SE SE7207999A patent/SE392899B/xx unknown
- 1972-06-17 ES ES403998A patent/ES403998A1/es not_active Expired
- 1972-06-19 NL NLAANVRAGE7208355,A patent/NL177893C/xx not_active IP Right Cessation
- 1972-06-19 JP JP6054172A patent/JPS5550943B1/ja active Pending
- 1972-06-19 AR AR242634A patent/AR192370A1/es active
-
1977
- 1977-07-29 US US05/820,489 patent/US4169158A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AR192370A1 (es) | 1973-02-14 |
US4169158A (en) | 1979-09-25 |
DE2229215A1 (de) | 1973-01-25 |
BE784727A (fr) | 1972-10-02 |
AU4350072A (en) | 1973-12-20 |
CH546769A (fr) | 1974-03-15 |
NL177893C (nl) | 1985-12-16 |
ES403998A1 (es) | 1975-06-01 |
FR2141697A1 (xx) | 1973-01-26 |
AU472247B2 (en) | 1973-12-20 |
JPS5550943B1 (xx) | 1980-12-20 |
FR2141697B1 (xx) | 1976-09-17 |
CA1003833A (en) | 1977-01-18 |
NL177893B (nl) | 1985-07-16 |
NL7208355A (xx) | 1972-12-20 |
GB1345880A (en) | 1974-02-06 |
DE2229215C2 (de) | 1984-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE392899B (sv) | Forfarande for framstellning av pyridazinderivat med psykotrop, serskilt antidepressiv verkan | |
SE393800B (sv) | Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt | |
SE415761B (sv) | Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan | |
SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
SE405599B (sv) | Forfarande for framstellning av pyridazinoner med terapeutisk verkan | |
SE385885B (sv) | Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat | |
SE395892B (sv) | Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan | |
SE401673B (sv) | Forfarande for framstellning av 2-substituerade 5-sulfamyl-bensoesyror med plasmalipidsenkande verkan | |
SE392615B (sv) | Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat | |
SE380273B (sv) | Forfarande for framstellning av tiopyrimidinderivat | |
SE397827B (sv) | Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan | |
SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
SE392722B (sv) | Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan | |
SE393982B (sv) | Sett att framstella dihydrokinolinderivat med antioxiderande verkan | |
SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
NO149775C (no) | Analogifremgangsmaate for fremstilling av fenyl-pyridylamin-derivater med antidepressiv virkning | |
SE409206B (sv) | Forfarande for framstellning av kinoxalindionderivat med hypnotisk verkan | |
SE401829B (sv) | Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav | |
SE425389B (sv) | Analogiforfarande for framstellning av vissa angivna oximetrar med antidepressiv verkan | |
SE380796B (sv) | Forfarande for framstellning av cyklopentanderivat | |
SE394429B (sv) | Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan | |
SE394680B (sv) | Forfarande for framstellning av cykliska fosfamidderivat | |
SE389108B (sv) | Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan | |
SE383738B (sv) | Forfarande for framstellning av sulfamoyl-bensensulfonamider med terapeutiska egenskaper | |
BE807842Q (fr) | Preparation de derives de quinoxaline-2-carboxamides |